Published in Int J Cancer on January 06, 1997
Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb Perspect Biol (2009) 2.89
Snail family transcription factors are implicated in thyroid carcinogenesis. Am J Pathol (2007) 1.17
Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody. Am J Pathol (1999) 1.13
Low frequency of E-cadherin alterations in familial breast cancer. Breast Cancer Res (2001) 1.04
E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus. Br J Cancer (1999) 0.94
E-cadherin gene mutations frequently occur in synovial sarcoma as a determinant of histological features. Am J Pathol (2001) 0.94
Molecular pathology of well-differentiated thyroid carcinomas. Virchows Arch (2005) 0.90
Immunoexpression of HBME-1, high molecular weight cytokeratin, cytokeratin 19, thyroid transcription factor-1, and E-cadherin in thyroid carcinomas. J Korean Med Sci (2005) 0.87
Role of E-cadherin gene in gall bladder cancer and its precursor lesions. Virchows Arch (2010) 0.86
Expression of P-cadherin identifies prostate-specific-antigen-negative cells in epithelial tissues of male sexual accessory organs and in prostatic carcinomas. Implications for prostate cancer biology. Am J Pathol (1997) 0.84
Genetic screening for familial gastric cancer. Hered Cancer Clin Pract (2004) 0.83
Diagnostic utility of immunohistochemical panel in various thyroid pathologies. Langenbecks Arch Surg (2010) 0.79
Association between E-cadherin (CDH1) polymorphisms and pancreatic cancer risk in Han Chinese population. Int J Clin Exp Pathol (2015) 0.77
Expression of E-Cadherin/Beta-Catenin in Epithelial Carcinomas of the Thyroid Gland. Open Access Maced J Med Sci (2017) 0.75
HPLC-DAD analysis, antioxidant potential and anti-urease activity of Asparagus gracilis collected from District Islamabad. BMC Complement Altern Med (2014) 0.75
The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell (2001) 10.02
Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell (1991) 8.75
E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J (1995) 4.55
The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci (2008) 3.77
The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates. EMBO J (2000) 3.77
Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members. J Mol Biol (2000) 3.52
E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene (1996) 3.35
The role of the ZEB family of transcription factors in development and disease. Cell Mol Life Sci (2009) 2.95
Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology (2001) 2.89
Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene (2007) 2.87
Mutations of the human E-cadherin (CDH1) gene. Hum Mutat (1998) 2.84
alpha-Catenin-vinculin interaction functions to organize the apical junctional complex in epithelial cells. J Cell Biol (1998) 2.74
Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol (1997) 2.15
Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene (1999) 2.10
Regulation of vimentin by SIP1 in human epithelial breast tumor cells. Oncogene (2006) 2.09
Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas. Cancer Res (1999) 2.09
Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res (1999) 2.09
E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer (1997) 2.02
The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer. Mol Cell Biol Res Commun (1999) 1.88
Molecular cloning of the human p120ctn catenin gene (CTNND1): expression of multiple alternatively spliced isoforms. Genomics (1998) 1.83
Snail promotes Wnt target gene expression and interacts with beta-catenin. Oncogene (2008) 1.76
Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer (1997) 1.69
Papillary and mucoepidermoid carcinoma of the thyroid with anaplastic transformation: a case report with histologic and immunohistochemical findings that support a provocative histogenetic hypothesis. Pathol Res Pract (1995) 1.65
Nuclear localization of the p120(ctn) Armadillo-like catenin is counteracted by a nuclear export signal and by E-cadherin expression. Proc Natl Acad Sci U S A (1999) 1.56
E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene (2001) 1.54
Microsatellite instability at multiple loci in gastric carcinoma: clinicopathologic implications and prognosis. Gastroenterology (1996) 1.51
E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas. Lab Invest (1999) 1.47
PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. J Clin Endocrinol Metab (2005) 1.46
Loss of Y chromosome in gastric carcinoma. Fact or artifact? Cancer Genet Cytogenet (1992) 1.45
Improved localization of phosphorylation sites in simian virus 40 large T antigen. J Virol (1983) 1.42
Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics (1995) 1.40
Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid. Br J Cancer (2005) 1.39
alphaT-catenin: a novel tissue-specific beta-catenin-binding protein mediating strong cell-cell adhesion. J Cell Sci (2001) 1.35
Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression. Br J Cancer (2003) 1.33
Genomic organization of the human beta-catenin gene (CTNNB1). Genomics (1996) 1.32
MUC1 gene polymorphism and gastric cancer--an epidemiological study. Glycoconj J (1997) 1.32
Expression of laminin, collagen IV, fibronectin, and type IV collagenase in gastric carcinoma. An immunohistochemical study of 87 patients. Cancer (1994) 1.31
Immunohistochemical study of the expression of MUC6 mucin and co-expression of other secreted mucins (MUC5AC and MUC2) in human gastric carcinomas. J Histochem Cytochem (2000) 1.25
Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma. Genes Chromosomes Cancer (2001) 1.24
Modulation of iron transport proteins in human colorectal carcinogenesis. Gut (2006) 1.23
New elements for an updated classification of the carcinomas of the stomach. Pathol Res Pract (1995) 1.22
Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas. Curr Genomics (2011) 1.18
The origin and significance of thyroid psammoma bodies. Lab Invest (1980) 1.17
Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells. Oncogene (2010) 1.16
Dimeric sialyl-Le(x) expression in gastric carcinoma correlates with venous invasion and poor outcome. Gastroenterology (1998) 1.15
delta-Protocadherins: a gene family expressed differentially in the mouse brain. Cell Mol Life Sci (2005) 1.12
Expression of fully and under-glycosylated forms of MUC1 mucin in gastric carcinoma. Int J Cancer (1998) 1.11
E-cadherin loss rather than beta-catenin alterations is a common feature of poorly differentiated thyroid carcinomas. Histopathology (2003) 1.10
E-cadherin and metastasin (mts-1/S100A4) expression levels are inversely regulated in two tumor cell families. Cancer Res (1998) 1.10
Plakophilin-3, a novel armadillo-like protein present in nuclei and desmosomes of epithelial cells. J Cell Sci (1999) 1.10
Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J Pathol (2000) 1.09
Hürthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance. Virchows Arch (2000) 1.09
The lipid phosphatase activity of PTEN is critical for stabilizing intercellular junctions and reverting invasiveness. J Cell Biol (2001) 1.08
Simple mucin-type carbohydrate antigens (Tn, sialosyl-Tn and T) in gastric mucosa, carcinomas and metastases. APMIS Suppl (1992) 1.07
Dysregulation of the E-cadherin/catenin complex by irreversible mutations in human carcinomas. Cell Adhes Commun (1998) 1.01
The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different "target genes": a study of the TGFbeta RII, IGFII R, and BAX genes. Am J Pathol (1998) 1.00
Microsatellite instability in hyperplastic and adenomatous polyps of the stomach. Cancer (1999) 1.00
Solitary fibrous tumour of the thyroid: clinicopathological, immunohistochemical and ultrastructural study of three cases. Virchows Arch A Pathol Anat Histopathol (1993) 0.98
The diagnostic value of flow cytometric DNA measurements in selected disorders of the human thyroid. Am J Clin Pathol (1982) 0.97
Immunohistochemical analysis of ras oncogene p21 product in human gastric carcinomas and their adjacent mucosas. Pathol Res Pract (1992) 0.97
Hodgkin's disease with predominant infradiaphragmatic involvement and massive invasion of the bone marrow. A necropsic study of nine cases. Cancer (1983) 0.96
Modulation of cellular susceptibility to the cytotoxic/cytostatic action of tumor necrosis factor by adenovirus E1 gene expression is cell type-dependent. Virology (1990) 0.96
Sporadic gastric carcinomas with microsatellite instability display a particular clinicopathologic profile. Int J Cancer (1995) 0.96
Proteolytic cleavage of beta-catenin by caspases: an in vitro analysis. FEBS Lett (1999) 0.95
Immunohistochemical expression of oncofetal fibronectin in benign and malignant lesions of the stomach. Eur J Cancer (1993) 0.95
Alpha-catulin, a Rho signalling component, can regulate NF-kappaB through binding to IKK-beta, and confers resistance to apoptosis. Oncogene (2007) 0.94
The human cadherin-10 gene: complete coding sequence, predominant expression in the brain, and mapping on chromosome 5p13-14. FEBS Lett (1999) 0.94
Establishment and characterization of two cell lines derived from human diffuse gastric carcinomas xenografted in nude mice. Virchows Arch (1996) 0.93
Identification of eleven novel tumor-associated E-cadherin mutations. Mutations in brief no. 215. Online. Hum Mutat (1999) 0.92
The protein-tyrosine phosphatase SHP-1 binds to and dephosphorylates p120 catenin. J Biol Chem (2000) 0.92
Synovial sarcoma. Evaluation of prognosis with emphasis on the study of DNA ploidy and proliferation (PCNA and Ki-67) markers. Anal Cell Pathol (1998) 0.92
Cadherin/catenin complex: a target for antiinvasive therapy? J Cell Biochem (1996) 0.92
Distinct deleted regions on chromosome segment 16q23-24 associated with metastases in prostate cancer. Genes Chromosomes Cancer (1999) 0.91
Human alpha-catulin, a novel alpha-catenin-like molecule with conserved genomic structure, but deviating alternative splicing. Biochim Biophys Acta (1999) 0.91
Metastatic thyroid carcinoma arising from congenital goiter due to mutation in the thyroperoxidase gene. J Clin Endocrinol Metab (1998) 0.91
Enhancement of tumor necrosis factor cytotoxicity by lithium chloride is associated with increased inositol phosphate accumulation. J Immunol (1993) 0.91
Abnormalities of the E-cadherin/catenin adhesion complex in classical papillary thyroid carcinoma and in its diffuse sclerosing variant. J Pathol (2001) 0.91
Sporadic ret-rearranged papillary carcinoma of the thyroid: a subset of slow growing, less aggressive thyroid neoplasms? J Pathol (1998) 0.90
Comments on: mutations in mitochondrial control region DNA in gastric tumours of Japanese patients, Tamura, et al. Eur J Cancer 1999, 35, 316-319. Eur J Cancer (1999) 0.89
Increasing levels of MYC and MET co-amplification during tumor progression of a case of gastric cancer. Cancer Genet Cytogenet (1995) 0.89
c-erbB-2 expression in primary gastric carcinomas and their metastases. Mod Pathol (1992) 0.89
Medullary thyroid carcinoma with thyroglobulin immunoreactivity. A special entity? Lab Invest (1987) 0.88
H-RAS 81 polymorphism is significantly associated with aneuploidy in follicular tumors of the thyroid. Oncogene (2006) 0.88
Immunohistochemical detection of p53 in differentiated, poorly differentiated and undifferentiated carcinomas of the thyroid. Histopathology (1994) 0.88
Cadherins in cancer. Handb Exp Pharmacol (2004) 0.87
Interference with simian virus 40 DNA replication by adenovirus type 2 during mixed infection of monkey cells. J Virol (1978) 0.86
Ki67 labelling index in gastric carcinomas. An immunohistochemical study using double staining for the evaluation of the proliferative activity of diffuse-type carcinomas. J Pathol (1997) 0.86
Spindle cell variant of papillary thyroid carcinoma. Histopathology (2004) 0.86
Diffuse sclerosing variant of papillary thyroid carcinoma. A clinicopathologic study of 10 cases. Pathol Res Pract (1989) 0.86
Lymphoid hypophysitis in a patient with lymphoid thyroiditis, lymphoid adrenalitis, and idiopathic retroperitoneal fibrosis. Arch Pathol Lab Med (1985) 0.86
Mitochondrial DNA 'common' deletion in Hürthle cell lesions of the thyroid. J Pathol (2000) 0.86
Cytogenetic findings in eleven gastric carcinomas. Cancer Genet Cytogenet (1993) 0.85